These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7636246)

  • 1. Structural requirements of peptide and MHC for DR(alpha, beta 1*0401)-restricted T cell antigen recognition.
    McNicholl JM; Whitworth WC; Oftung F; Fu X; Shinnick T; Jensen PE; Simon M; Wohlhueter RM; Karr RW
    J Immunol; 1995 Aug; 155(4):1951-63. PubMed ID: 7636246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
    J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules.
    Geluk A; Bloemhoff W; De Vries RR; Ottenhoff TH
    Eur J Immunol; 1992 Jan; 22(1):107-13. PubMed ID: 1370411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
    Boehncke WH; Takeshita T; Pendleton CD; Houghten RA; Sadegh-Nasseri S; Racioppi L; Berzofsky JA; Germain RN
    J Immunol; 1993 Jan; 150(2):331-41. PubMed ID: 8093457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor and peptide-contacting residues in the HLA-DR17(3) beta 1 chain.
    Geluk A; Fu XT; van Meijgaarden KE; Jansen YY; De Vries RR; Karr RW; Ottenhoff TH
    Eur J Immunol; 1994 Dec; 24(12):3241-4. PubMed ID: 7805754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides.
    Geluk A; Van Meijgaarden KE; Janson AA; Drijfhout JW; Meloen RH; De Vries RR; Ottenhoff TH
    J Immunol; 1992 Nov; 149(9):2864-71. PubMed ID: 1383331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microheterogeneity in the recognition of a HLA-DR2-restricted T cell epitope from a meningococcal outer membrane protein.
    Wiertz E; van Gaans-van den Brink J; Hoogerhout P; Poolman J
    Eur J Immunol; 1993 Jan; 23(1):232-9. PubMed ID: 7678224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
    J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.
    Marshall KW; Liu AF; Canales J; Perahia B; Jorgensen B; Gantzos RD; Aguilar B; Devaux B; Rothbard JB
    J Immunol; 1994 May; 152(10):4946-57. PubMed ID: 8176213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
    Lee JM; McKean DJ; Watts TH
    J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual effects of the DR11-variable beta-chain residues 67, 71, and 86 upon DR(alpha,beta 1*1101)-restricted, peptide-specific T cell proliferation.
    McKinney JS; Fu XT; Swearingen C; Klohe E; Karr RW
    J Immunol; 1994 Dec; 153(12):5564-71. PubMed ID: 7989758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition.
    Krieger JI; Karr RW; Grey HM; Yu WY; O'Sullivan D; Batovsky L; Zheng ZL; Colón SM; Gaeta FC; Sidney J
    J Immunol; 1991 Apr; 146(7):2331-40. PubMed ID: 1706393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T cell recognition.
    Signorelli KL; Watts LM; Lambert LE
    Cell Immunol; 1995 May; 162(2):217-24. PubMed ID: 7743549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the permissive association of a malaria T cell epitope with DR molecules.
    Kilgus J; Jardetzky T; Gorga JC; Trzeciak A; Gillessen D; Sinigaglia F
    J Immunol; 1991 Jan; 146(1):307-15. PubMed ID: 1701796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
    Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
    J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
    Smith KD; Lutz CT
    J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II binding of peptides derived from HLA-DR 1.
    Harris PE; Liu Z; Suciu-Foca N
    J Immunol; 1992 Apr; 148(7):2169-74. PubMed ID: 1545124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A toxic shock syndrome toxin-1 peptide that shows homology to mycobacterial heat shock protein 18 is presented as conventional antigen to T cells by multiple HLA-DR alleles.
    Ramesh N; Spertini F; Scholl P; Geha R
    J Immunol; 1992 Feb; 148(4):1025-30. PubMed ID: 1737925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.